Postmenopausal estrogen use and invasive versus in situ breast cancer risk

Journal of Clinical Epidemiology

Volumn 51, Issue 12, 1998, Pages 1277-1283

  Henrich, Janet B ^a   Kornguth, Phyllis J ^b   Viscoli, Catherine M ^a   Horwitz, Ralph I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Clinical epidemiology; Estrogen replacement therapy; Postmenopausal

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; POSTMENOPAUSE;

EID: 0032417076     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00116-4     Document Type: Article

References (35)

1. Yang C.P., Daling J.R., Band P.R., Gallagher R.P., White E., Weiss N.S. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control. 3:1992;475-479.
2. Palmer J.R., Rosenberg L., Clarke E.A., Miller D.R., Shapiro S. Breast cancer risk after estrogen replacement therapy. Results from the Toronto Breast Cancer Study Am J Epidemiol. 134:1991;1386-1395.
3. DuPont W.D., Page D.L., Rogers L.W., Parl F.F. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer. 63:1989;948-957.
4. Brownson R.C., Blackwell C.W., Pearson D.K., Reynolds R.D., Richens J.W., Papermaster B.W. Risk of breast cancer in relation to cigarette smoking. Arch Intern Med. 148:1988;140-144.
5. Rohan T.E., McMichael A.J. Non-contraceptive exogenous oestrogen therapy and breast cancer. Med J Aust. 148:1988;217-221.
6. Wingo P.A., Layde P.M., Lee N.C., Rubin G., Ory H.W. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA. 257:1987;209-215.
7. Buring J.E., Hennekens C.H., Lipnick R.J.et al. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol. 125:1987;939-947.
8. Brinton L.A., Hoover R., Fraumeni J.F. Jr. Menopausal oestrogens and breast cancer risk. An expanded case-control study Br J Cancer. 54:1986;825-832.
9. Nomura A.M., Kolonel L.N., Hirohata T., Lee J. The association of replacement estrogens with breast cancer. Int J Cancer. 37:1986;49-53.
10. Hiatt R.A., Bawol R., Friedman G.D., Hoover R. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer. 54:1984;139-144.
11. Horwitz R.I., Stewart K.R. Effect of clinical features on the association of estrogens and breast cancer. Am J Med. 76:1984;192-198.
12. Kaufman D.W., Miller D.R., Rosenberg L.et al. Noncontraceptive estrogen use and the risk of breast cancer. JAMA. 252:1984;63-67.
13. Sherman B., Wallace R., Bean J. Estrogen use and breast cancer. Interaction with body mass. Cancer. 51:1983;1527-1531.
14. Gambrell R.D., Maier R.C., Sanders B.I. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol. 62:1983;435-443.
15. Kelsey J.L., Fischer D.B., Holford T.R., LiVoisi V.A., Mostow E.D., Goldenberg I.S. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst. 67:1981;327-333.
16. Stanford J.L., Weiss N.S., Voigt L.F., Daling J.R., Habel L.A., Rossing M.A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 274:1995;137-142.
17. Schairer C., Byrne C., Keyle P.M., Brinton L.A., Sturgeon S.R., Hoover R.N. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control. 5:1994;491-500.
18. Schuurman A.G., van den Brandt P.A., Goldbohm R.A. Exogenous hormone use and the risk of postmenopausal breast cancer. results from the Netherlands Cohort Study Cancer Causes Control. 6:1995;414-424.
19. LaVecchia C., Negri E., Franceschi S., Favero A., Nanni O., Filiberti R. Hormone replacement treatment and breast cancer risk. A cooperative Italian study Br J Cancer. 72:1995;244-248.
20. Weinstein A.L., Mahoney M.C., Nasca P.C., Hanson R.L., Leske M.C., Varma A.O. Oestrogen replacement therapy and breast cancer risk. A case-control study Int J Epidemiol. 22:1993;781-789.
21. Kaufman D.W., Palmer J.R., deMouzon J., Rosenberg L., Stolley P.D., Warshauer M.E. Estrogen replacement therapy and the risk of breast cancer. Results from the Case-Control Surveillance Study Am J Epidemiol. 134:1991;1375-1385.
22. Colditz G.A., Stampfer M.J., Willett W.C., Hennekens C.H., Rosner B., Speizer F.E. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 264:1990;2648-2653.
23. Bergkvist L., Adami H.O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 321:1989;293-297.
24. Mills P.K., Beeson W.L., Phillips R.L., Fraser G.E. Prospective study of exogenous hormone use and breast cancer in seventh-day adventists. Cancer. 64:1989;591-597.
25. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer. 42:1988;832-838.
26. Hunt K., Vessey M., McPherson K., Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 94:1987;620-635.
27. Hulka B.S., Chambless L.E., Deubner D.C., Wilkinson W.E. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol. 143:1982;638-644.
28. Thomas D.B., Persing J.P., Hutchinson W.B. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst. 69:1982;1017-1025.
29. Hoover R., Glass A., Finkle W.D., Azevedo D., Milne K. Conjugated estrogens and breast cancer risk in women. J Natl Cancer Inst. 67:1981;815-820.
30. Ross R.K., Paganini-Hill A., Gerkins V.R., Mack T.M., Pfeffer R., Arthur M. A case-control study of menopausal estrogen therapy and breast cancer. JAMA. 243:1980;1635-1639.
31. Harris R.E., Namboodiri K.K., Wynder E.L. Breast cancer risk. Effects of estrogen replacement and body mass J Natl Cancer Inst. 84:1992;1575-1582.
32. Newcomb P.A., Longnecker M.P., Storer B.E., Mittendorf R., Baron J., Clapp R.W. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol. 142:1995;788-795.
33. Risch H.A., Howe G.R. Menopausal hormone usage and breast cancer in Saskatchewan. A record-linkage cohort study Am J Epidemiol. 139:1994;670-683.
34. Colditz G.A., Hankinson S.E., Hunter D.J., Willet W.C., Manson J.E., Stampfer M.J. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 332:1995;1589-1593.
35. Collaborative Group of Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiologic studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047-1059.